Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+33.4%
5Y CAGR+48.2%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+33.4%/yr
vs +361.5%/yr prior
5Y CAGR
+48.2%/yr
Recent deceleration
Acceleration
-328.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
7.2x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $198.34M | +26.5% |
| 2024 | $156.81M | +29.3% |
| 2023 | $121.24M | +45.2% |
| 2022 | $83.48M | +50.4% |
| 2021 | $55.52M | +100.2% |
| 2020 | $27.74M | +1658.9% |
| 2019 | $1.58M | +757.1% |
| 2018 | $184000.00 | - |